News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bostwick Laboratories: New Personalized Genetic Test- ProstaVysionTM- Helps Prostate Cancer Patients Make Best Treatment Decisions


5/12/2011 11:24:51 AM

Treatment of prostate cancer is often confusing for patients, but ProstaVysion™ – the first personalized genetic panel for prostate cancer – optimizes that choice by defining the aggressiveness of the cancer. Exclusively from Bostwick Laboratories® and available immediately, ProstaVysionTM examines the genetic status of that patient’s prostate cancer.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES